Patents by Inventor Kevin Lewis Otipoby

Kevin Lewis Otipoby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190321446
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 24, 2019
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169255
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 MUTEINS AND USES THEREOF
    Publication number: 20190169254
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 6, 2019
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174091
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins
    Patent number: 10174092
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 8, 2019
    Assignee: Pandion Therapeutics, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby